Zhejiang Dayang Biotech Group Co Total Liabilities
Zhejiang Dayang Biotech Group Co total liabilities. Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has total liabilities worth CN¥706.73 Million CNY (≈ $103.42 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhejiang Dayang Biotech Group Co liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Dayang Biotech Group Co (2013–2025)
Total liabilities of Zhejiang Dayang Biotech Group Co from 2013 to 2025. This chart illustrates how Zhejiang Dayang Biotech Group Co's total liabilities have evolved over time, based on quarterly financial data.
Zhejiang Dayang Biotech Group Co Competitors by Total Liabilities
The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Canopy Growth Corp
TO:WEED
|
Canada | CA$415.29 Million |
|
TRX Gold Corporation
TO:TRX
|
Canada | CA$45.94 Million |
|
Funeng Oriental Equipment Technology Co Ltd
SHE:300173
|
China | CN¥2.71 Billion |
|
Sillo Maritime Perdana Tbk PT
JK:SHIP
|
Indonesia | Rp247.06 Million |
|
United Malacca Bhd
KLSE:2593
|
Malaysia | RM262.46 Million |
|
Empresa Distribuidora y Comercializadora Norte Sociedad Anónima
F:PWD1
|
Germany | €3.54 Trillion |
|
NACL Industries Limited
NSE:NACLIND
|
India | Rs-6.83 Billion |
|
Artesian Resources Corporation
NASDAQ:ARTNA
|
USA | $627.78 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Zhejiang Dayang Biotech Group Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Zhejiang Dayang Biotech Group Co balance sheet assets.
Liquidity & Leverage Metrics
Zhejiang Dayang Biotech Group Co Total Liabilities Ratios Explained
Zhejiang Dayang Biotech Group Co total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Dayang Biotech Group Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Dayang Biotech Group Co (2013–2025)
The table below shows the annual total liabilities of Zhejiang Dayang Biotech Group Co from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥681.72 Million ≈ $99.76 Million |
+13.54% |
| 2024-12-31 | CN¥600.40 Million ≈ $87.86 Million |
+11.50% |
| 2023-12-31 | CN¥538.47 Million ≈ $78.79 Million |
+2.97% |
| 2022-12-31 | CN¥522.92 Million ≈ $76.52 Million |
+36.31% |
| 2021-12-31 | CN¥383.64 Million ≈ $56.14 Million |
+41.74% |
| 2020-12-31 | CN¥270.67 Million ≈ $39.61 Million |
+83.49% |
| 2019-12-31 | CN¥147.51 Million ≈ $21.59 Million |
-8.37% |
| 2018-12-31 | CN¥160.99 Million ≈ $23.56 Million |
-8.20% |
| 2017-12-31 | CN¥175.37 Million ≈ $25.66 Million |
-26.12% |
| 2016-12-31 | CN¥237.37 Million ≈ $34.73 Million |
-4.72% |
| 2015-12-31 | CN¥249.12 Million ≈ $36.45 Million |
-6.50% |
| 2014-12-31 | CN¥266.43 Million ≈ $38.99 Million |
+4.92% |
| 2013-12-31 | CN¥253.93 Million ≈ $37.16 Million |
-- |
About Zhejiang Dayang Biotech Group Co
Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium bicarbonate, ammonium chloride, manufactures and sales bicarbonate food and feed additives; veterinary drugs; potassium bicarbonate; and ammonium chloride. It also provides 2-chloro-6-fluorobenzoic acid, fluoro… Read more